Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06591338 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIA

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 5, 2025 (before its estimated September 15, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion date: Sep 15, 2024 to Sep 15, 2025v2 Show 4 more changesShow less
    • Start date: Apr 1, 2022 to Sep 1, 2024
    • Study completion date: Sep 30, 2024 to Oct 10, 2025
    • Interventions: Clopidogrel (Drug), Ticagrelor 90 MG (Drug) to Aspirin 75 Mg Oral Tablet (Drug), Aspirin 75 Mg Oral Tablet (Drug), Clopidogrel (Drug), Ticagrelor 90 MG (Drug)
    • Study description revised
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
3,531 trials monitored
See 153 trials at risk
Along with the current clinical trial, the efficacy and safety of a 180 mg loading dose of ticagrelor administered within 24 hours of the first-ever large-vessel minor stroke or TIA compared to 300 mg clopidogrel were assessed through NIHSS, mRS, and possible adverse effects.
Trial Details
NCT Number NCT06591338
Lead Sponsor Kafrelsheikh University
Conditions
(from sponsor)
Ischemic Stroke
Related terms Ischemic Stroke
Enrollment 900 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov